The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.
Open accessAbstract
Antioncogene product p53 is a transcriptional transactivator. To investigate how p53 stimulates transcription, we examined the interaction of p53 with general transcription factors in vitro. We found that p53 binds directly to the human TATA box-binding polypeptide (TBP). We also observed a direct interaction between p53 and purified holo-TFIID, a complex composed of TBP and a group of TBP-associated polypeptides known as TAFs. The p53 binding domain on TBP was mapped to the conserved region of TBP, including residues 220 to 271. The TBP binding domain on p53 was mapped to the p53 activation domain between residues 20 and 57. To analyze the significance of the p53-TBP interaction in p53 transactivation, we compared the ability of Gal4-p53 fusion proteins to bind to TBP in vitro and to activate transcription in transient transfection assays. Fusion proteins which bound to TBP activated transcription, and those that did not bind to TBP did not activate transcription to a detectable level, suggesting that a direct interaction between TBP and p53 is required for p53 transactivation. We also found that inclusion of residues 93 to 160 of p53 in a Gal4-p53 fusion repressed transcriptional activation 100-fold. Consequently, this region of p53 inhibits transcriptional activation by the minimal p53 activation domain. Highest levels of activation were observed with sequences 1 to 92 of p53 fused to Gal4, even though this construct bound to TBP in vitro with an affinity similar to that of other Gal4-p53 fusion proteins. We conclude that TBP binding is necessary for p53 transcriptional activation and that p53 sequences outside the TBP binding domain modulate the level of activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
[6] Use of T7 RNA polymerase to direct expression of cloned genes
William Studier, F., Rosenberg, A. H., Dunn, J. J., & Dubendorff, J. W. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)85008-c · Cited by 6,562
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,892
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
How eukaryotic transcriptional activators work
Ptashne, M. (1988) · Nature · doi:10.1038/335683a0 · Cited by 1,825
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,754
GAL4-VP16 is an unusually potent transcriptional activator
Sadowski, I., Ma, J., Triezenberg, S., & Ptashne, M. (1988) · Nature · doi:10.1038/335563a0 · Cited by 1,333
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., & Tlsty, T. D. (1992) · Cell · doi:10.1016/0092-8674(92)90243-6 · Cited by 1,332
Takebe, Y., Seiki, M., Fujisawa, J.-I., Hoy, P., Yokota, K., Arai, K.-I., Yoshida, M., & Arai, N. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.466-472.1988 · Cited by 1,330
Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., & Wahl, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90244-7 · Cited by 1,089
Monoclonal antibodies specific for simian virus 40 tumor antigens
Harlow, E., Crawford, L. V., Pim, D. C., & Williamson, N. M. (1981) · Journal of Virology · doi:10.1128/jvi.39.3.861-869.1981 · Cited by 1,039
Five intermediate complexes in transcription initiation by RNA polymerase II
Buratowski, S., Hahn, S., Guarente, L., & Sharp, P. A. (1989) · Cell · doi:10.1016/0092-8674(89)90578-3 · Cited by 1,027
Oncogenic forms of p53 inhibit p53-regulated gene expression
Kern, S., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940
Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma
Herbomel, P., Bourachot, B., & Yaniv, M. (1984) · Cell · doi:10.1016/0092-8674(84)90472-0 · Cited by 837
p53: oncogene or anti-oncogene?
Lane, D. P., & Benchimol, S. (1990) · Genes & Development · doi:10.1101/gad.4.1.1 · Cited by 795
Presence of a Potent Transcription Activating Sequence in the p53 Protein
Fields, S., & Jang, S. K. (1990) · Science · doi:10.1126/science.2144363 · Cited by 790
p53 functions as a cell cycle control protein in osteosarcomas.
Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., & Vogelstein, B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5772 · Cited by 772
Wild-type p53 can inhibit oncogene-mediated focus formation.
Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., & Oren, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8763 · Cited by 692
Dynlacht, B. D., Hoey, T., & Tjian, R. (1991) · Cell · doi:10.1016/0092-8674(81)90019-2 · Cited by 683
Transcription activation by the adenovirus E1a protein
Lillie, J. W., & Green, M. R. (1989) · Nature · doi:10.1038/338039a0 · Cited by 632
Transcriptional Activation by Wild-Type but Not Transforming Mutants of the p53 Anti-Oncogene
Raycroft, L., Wu, H., & Lozano, G. (1990) · Science · doi:10.1126/science.2144364 · Cited by 619
Keegan, L., Gill, G., & Ptashne, M. (1986) · Science · doi:10.1126/science.3080805 · Cited by 612
Wild-type p53 activates transcription in vitro
Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., & Prives, C. (1992) · Nature · doi:10.1038/358083a0 · Cited by 579 · cited 3×
“Previous experiments have shown that p53 binds to DNA and activates transcription both in vivo and in vitro (9, 10, 22).”
Stringer, K. F., Ingles, C. J., & Greenblatt, J. (1990) · Nature · doi:10.1038/345783a0 · Cited by 579
Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein
Yew, P. R., & Berk, A. J. (1992) · Nature · doi:10.1038/357082a0 · Cited by 561
Self-citationPtashne, M., & Gann, A. A. F. (1990) · Nature · doi:10.1038/346329a0 · Cited by 549
Mechanism of action of an acidic transcriptional activator in vitro
Lin, Y.-S., & Green, M. R. (1991) · Cell · doi:10.1016/0092-8674(91)90321-o · Cited by 530
Wild-type p53 binds to the TATA-binding protein and represses transcription.
Seto, E., Usheva, A., Zambetti, G. P., Momand, J., Horikoshi, N., Weinmann, R., Levine, A. J., & Shenk, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12028 · Cited by 504
RNA POLYMERASE B (II) AND GENERAL TRANSCRIPTION FACTORS
Sawadogo, M., & Sentenac, A. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.003431 · Cited by 441
Crystal structure of TFIID TATA-box binding protein
Nikolov, D. B., Hu, S.-H., Lin, J., Gasch, A., Hoffmann, A., Horikoshi, M., Chua, N.-H., Roeder, R. G., & Burley, S. K. (1992) · Nature · doi:10.1038/360040a0 · Cited by 405
NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats
Blank, V., Kourilsky, P., & Israël, A. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90321-y · Cited by 393
Binding of general transcription factor TFIIB to an acidic activating region
Lin, Y.-S., Ha, I., Maldonado, E., Reinberg, D., & Green, M. R. (1991) · Nature · doi:10.1038/353569a0 · Cited by 366
Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor
Lee, W. S., Kao, C. C., Bryant, G. O., Liu, X., & Berk, A. J. (1991) · Cell · doi:10.1016/0092-8674(91)90188-5 · Cited by 365
Self-citationHolo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter.
Zhou, Q., Lieberman, P. M., Boyer, T. G., & Berk, A. J. (1992) · Genes & Development · doi:10.1101/gad.6.10.1964 · Cited by 361
Self-citationCoactivators for a proline-rich activator purified from the multisubunit human TFIID complex.
Tanese, N., Pugh, B. F., & Tjian, R. (1991) · Genes & Development · doi:10.1101/gad.5.12a.2212 · Cited by 346
Reduced binding of TFIID to transcriptionally compromised mutants of VP16
Ingles, C. J., Shales, M., Cress, W. D., Triezenberg, S. J., & Greenblatt, J. (1991) · Nature · doi:10.1038/351588a0 · Cited by 327
Vogelstein, B. (1990) · Nature · doi:10.1038/348681a0 · Cited by 324
Cloning of a Transcriptionally Active Human TATA Binding Factor
Kao, C. C., Lieberman, P. M., Schmidt, M. C., Zhou, Q., Pei, R., & Berk, A. J. (1990) · Science · doi:10.1126/science.2194289 · Cited by 316
Self-citationZambetti, G. P., Bargonetti, J., Walker, K., Prives, C., & Levine, A. J. (1992) · Genes & Development · doi:10.1101/gad.6.7.1143 · Cited by 311
Physical Analysis of Transcription Preinitiation Complex Assembly on a Class II Gene Promoter
Dyke, M. W. V., Roeder, R. G., & Sawadogo, M. (1988) · Science · doi:10.1126/science.3413495 · Cited by 309
Cloning of a human gene encoding the general transcription initiation factor IIB
Ha, I., Lane, W. S., & Reinberg, D. (1991) · Nature · doi:10.1038/352689a0 · Cited by 270
Flores, O., Lu, H., & Reinberg, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45947-9 · Cited by 230
Lieberman, P. M., & Berk, A. J. (1991) · Genes & Development · doi:10.1101/gad.5.12b.2441 · Cited by 229
Self-citationTruant, R., Xiao, H., Ingles, C. J., & Greenblatt, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53769-8 · Cited by 203
The MCK enhancer contains a p53 responsive element.
Weintraub, H., Hauschka, S., & Tapscott, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4570 · Cited by 159
Bull, P., Morley, K. L., Hoekstra, M. F., Hunter, T. R., & Verma, I. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.10.5473 · Cited by 152
The mammalian TFIID protein is present in two functionally distinct complexes.Preprint
Timmers, H. T. M., & Sharp, P. A. (1991) · Genes & Development · doi:10.1101/gad.5.11.1946 · Cited by 135
A potential transcriptional activation element in the p53 protein.
O’Rourke, R. W., Cw, M., Kato, G. J., Simon, K. J., Dl, C., Dang, C. V., & Hp, K. (1990) · PubMed · Cited by 128
Molecular Basis for Heterogeneity of the Human p53 Protein
Harris, N., Brill, E., Shohat, O., Prokocimer, M., Wolf, D., Arai, N., & Rotter, V (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4650 · Cited by 79
Cited by
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 and Human Cancer: The First Ten Thousand Mutations
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60785-x · Cited by 986
Regulation ofp53downstream genes
El-Deiry, W. S. (1998) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0097 · Cited by 800
Chen, X., Ko, L. J., Jayaraman, L., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.19.2438 · Cited by 735
Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R., & Harris, C. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2230 · Cited by 665
Metadata
- Authors
- Liu, X., Miller, C. W., Koeffler, P. H., & Berk, A. J.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1993-06
- Volume
- 13
- Issue
- 6
- Pages
- 3291-3300
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W1860047937
- Cited by
- 260
- References
- 53
- FWCI
- 17.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.